Balaguer, Julia
García Hidalgo, Laura
Hladun, Raquel
Márquez Vega, Catalina
Pérez Alonso, Vanesa
Funding for this research was provided by:
EUSA Pharma Iberia S.L.
Article History
Accepted: 31 October 2022
First Online: 12 December 2022
Declarations
:
: All authors contributed equally to the conception, writing and critical revision of this manuscript, and have read and agreed on the final version.
: Medical writing assistance was funded by EUSA Pharma Iberia S.L. EUSA Pharma had the opportunity to provide a courtesy review of the manuscript but the final content is the responsibility of the authors alone.
: Julia Balaguer, Laura García Hidalgo and Catalina Marquez Vega report advisory fees and support for travel to meetings from EUSA Pharma. Vanesa Pérez Alonso reports advisory fees from EUSA Pharma. Raquel Hladun reports advisory fees and support for lectures and travel to meetings from EUSA Pharma.